BRPI1016174A2 - tia-triaza-ciclopentazulenos como inibidores de pi3-cinases para o tratamento de câncer - Google Patents
tia-triaza-ciclopentazulenos como inibidores de pi3-cinases para o tratamento de câncerInfo
- Publication number
- BRPI1016174A2 BRPI1016174A2 BRPI1016174A BRPI1016174A BRPI1016174A2 BR PI1016174 A2 BRPI1016174 A2 BR PI1016174A2 BR PI1016174 A BRPI1016174 A BR PI1016174A BR PI1016174 A BRPI1016174 A BR PI1016174A BR PI1016174 A2 BRPI1016174 A2 BR PI1016174A2
- Authority
- BR
- Brazil
- Prior art keywords
- cyclopentazulenes
- triaza
- thia
- kinases
- inhibitors
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 title 1
- 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09158493 | 2009-04-22 | ||
| PCT/EP2010/055295 WO2010122071A1 (en) | 2009-04-22 | 2010-04-21 | Thia-triaza-cyclopentazulenes as pi3-kinases inhibitors for the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1016174A2 true BRPI1016174A2 (pt) | 2016-04-19 |
Family
ID=40996623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1016174A BRPI1016174A2 (pt) | 2009-04-22 | 2010-04-21 | tia-triaza-ciclopentazulenos como inibidores de pi3-cinases para o tratamento de câncer |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8288379B2 (pt) |
| EP (1) | EP2421871B1 (pt) |
| JP (1) | JP5658231B2 (pt) |
| KR (1) | KR20120014152A (pt) |
| CN (1) | CN102459282A (pt) |
| AP (1) | AP2011005893A0 (pt) |
| AR (1) | AR076364A1 (pt) |
| AU (1) | AU2010240965A1 (pt) |
| BR (1) | BRPI1016174A2 (pt) |
| CA (1) | CA2759595A1 (pt) |
| CO (1) | CO6460760A2 (pt) |
| EA (1) | EA201101537A1 (pt) |
| EC (1) | ECSP11011464A (pt) |
| IL (1) | IL215199A0 (pt) |
| MA (1) | MA33223B1 (pt) |
| MX (1) | MX2011011065A (pt) |
| SG (1) | SG175746A1 (pt) |
| TN (1) | TN2011000530A1 (pt) |
| TW (1) | TW201103942A (pt) |
| UY (1) | UY32566A (pt) |
| WO (1) | WO2010122071A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20160091060A (ko) | 2015-01-23 | 2016-08-02 | 전관식 | 약제 분배장치 및 분말약 분배방법 |
| ITRM20150212A1 (it) * | 2015-05-15 | 2016-11-15 | Univ Degli Studi Di Palermo | 4,5,6,9-tetraidropirrolo[2',3':3,4] cicloepta[1,2-d] isossazoli, procedimento per la loro produzione e loro uso come antitumorali |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9024A (en) * | 1852-06-15 | Motion of the lay in looms | ||
| US5547975A (en) * | 1994-09-20 | 1996-08-20 | Talley; John J. | Benzopyranopyrazolyl derivatives for the treatment of inflammation |
| UY29149A1 (es) | 2004-10-07 | 2006-05-31 | Boehringer Ingelheim Int | Tiazolil-dihidro-indazoles |
| KR20070064660A (ko) | 2004-10-07 | 2007-06-21 | 베링거 인겔하임 인터내셔날 게엠베하 | Ｐｉ３ 키나제 |
| US8779154B2 (en) * | 2006-09-26 | 2014-07-15 | Qinglin Che | Fused ring compounds for inflammation and immune-related uses |
| US9243000B2 (en) * | 2009-04-22 | 2016-01-26 | Boehringer Ingelheim International Gmbh | Thia-triaza-indacenes |
-
2010
- 2010-04-20 US US12/763,537 patent/US8288379B2/en active Active
- 2010-04-21 SG SG2011076478A patent/SG175746A1/en unknown
- 2010-04-21 JP JP2012506483A patent/JP5658231B2/ja active Active
- 2010-04-21 UY UY0001032566A patent/UY32566A/es not_active Application Discontinuation
- 2010-04-21 TW TW099112536A patent/TW201103942A/zh unknown
- 2010-04-21 CN CN2010800281306A patent/CN102459282A/zh active Pending
- 2010-04-21 AU AU2010240965A patent/AU2010240965A1/en not_active Abandoned
- 2010-04-21 EA EA201101537A patent/EA201101537A1/ru unknown
- 2010-04-21 MX MX2011011065A patent/MX2011011065A/es not_active Application Discontinuation
- 2010-04-21 WO PCT/EP2010/055295 patent/WO2010122071A1/en active Application Filing
- 2010-04-21 AR ARP100101322A patent/AR076364A1/es unknown
- 2010-04-21 CA CA2759595A patent/CA2759595A1/en not_active Abandoned
- 2010-04-21 EP EP10714018.8A patent/EP2421871B1/en active Active
- 2010-04-21 KR KR1020117027380A patent/KR20120014152A/ko not_active Application Discontinuation
- 2010-04-21 AP AP2011005893A patent/AP2011005893A0/xx unknown
- 2010-04-21 MA MA34284A patent/MA33223B1/fr unknown
- 2010-04-21 BR BRPI1016174A patent/BRPI1016174A2/pt not_active Application Discontinuation
-
2011
- 2011-09-18 IL IL215199A patent/IL215199A0/en unknown
- 2011-10-20 TN TNP2011000530A patent/TN2011000530A1/en unknown
- 2011-11-11 CO CO11154168A patent/CO6460760A2/es not_active Application Discontinuation
- 2011-11-17 EC EC2011011464A patent/ECSP11011464A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2421871B1 (en) | 2015-09-16 |
| CO6460760A2 (es) | 2012-06-15 |
| AR076364A1 (es) | 2011-06-08 |
| AP2011005893A0 (en) | 2011-10-31 |
| JP2012524751A (ja) | 2012-10-18 |
| TW201103942A (en) | 2011-02-01 |
| IL215199A0 (en) | 2011-12-29 |
| SG175746A1 (en) | 2011-12-29 |
| EP2421871A1 (en) | 2012-02-29 |
| US8288379B2 (en) | 2012-10-16 |
| ECSP11011464A (es) | 2011-12-30 |
| TN2011000530A1 (en) | 2013-05-24 |
| US20110112087A1 (en) | 2011-05-12 |
| CA2759595A1 (en) | 2010-10-28 |
| UY32566A (es) | 2010-11-30 |
| EA201101537A1 (ru) | 2012-05-30 |
| MA33223B1 (fr) | 2012-04-02 |
| AU2010240965A1 (en) | 2011-10-20 |
| MX2011011065A (es) | 2011-11-04 |
| JP5658231B2 (ja) | 2015-01-21 |
| CN102459282A (zh) | 2012-05-16 |
| KR20120014152A (ko) | 2012-02-16 |
| WO2010122071A1 (en) | 2010-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1243919A1 (zh) | 利用tor激酶抑制劑治療癌症 | |
| IL274318A (en) | Cancer treatment with rapamycin target site kinase inhibitors | |
| BR112012030923A2 (pt) | derivados de piperidinona como inibidores mdm2 para o tratamento de câncer | |
| BR112012001325A2 (pt) | tratamento de distúrbios do fígado com inibidaores de pi3k | |
| IL232530B (en) | A combination of factors for cancer treatment | |
| BRPI1013618A2 (pt) | pirimidinas substituídas para o tratamento de câncer | |
| BRPI0908127A2 (pt) | Método para o tratamento do câncer da próstata com degarelix antagonista do gnrh | |
| HK1202247A1 (en) | Treatment of cancer with tor kinase inhibitors tor | |
| HK1201750A1 (en) | Treatment of cancer with tor kinase inhibitors tor | |
| BRPI1010874A8 (pt) | composição para o tratamento de câncer de próstata | |
| BRPI1007972A2 (pt) | composições de combinação e métodos para o tratamento de câncer | |
| HK1193823A1 (zh) | 用於治療癌症的作為 -激酶抑制劑的苯並吡喃酮化合物 | |
| HK1201753A1 (en) | Treatment of cancer with tor kinase inhibitors tor | |
| BRPI1015274A2 (pt) | instalação para o tratamento de superfície de peças | |
| UY33155A (es) | Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa | |
| BR112012005343A2 (pt) | sulfonamidas como inibidores de proteínas da família bcl-2 para o tratamento de câncer | |
| SG10201502566SA (en) | Use of novel pan-cdk inhibitors for treating tumors | |
| BR112013028890A2 (pt) | composições e métodos para o tratamento de câncer | |
| EP2897607A4 (en) | BETA-HYDROLASE INHIBITORS FOR THE TREATMENT OF CANCER | |
| BR112012013591A2 (pt) | dispositivo para tratamento eletroterapêutico | |
| BR112012004701A2 (pt) | compostos e composições para tratamento do câncer | |
| BRPI1009435A2 (pt) | tratamento para câncer no pâncreas | |
| BRPI1016174A2 (pt) | tia-triaza-ciclopentazulenos como inibidores de pi3-cinases para o tratamento de câncer | |
| ZA201202379B (en) | Antagonists of dsgs2 for treatment of cancer | |
| BR112013007841A2 (pt) | derivador de 4- (metilaminofenoxi) piridina - 3 - yl - benzamida para tratamento de câncer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |